Literature DB >> 15902968

Statin-induced muscle necrosis in the rat: distribution, development, and fibre selectivity.

F Russell Westwood1, Alison Bigley, Kevin Randall, Alan M Marsden, Robert C Scott.   

Abstract

Simvastatin and cerivastatin have been used to investigate the development of statin-induced muscle necrosis in the rat. This was similar for both statins and was treatment-duration dependent, only occurring after 10 days had elapsed even if the dose was increased, and still occurring after this time when dosing was terminated earlier as a result of morbidity. It was then widespread and affected all areas of the muscular system. However, even when myotoxicity was severe, particular individual muscles and some types of fibres within affected muscles were spared consistently. Fibre typing of spared muscles and of acutely necrotic fibres within affected muscles indicated a differential fibre sensitivity to statin-induced muscle necrosis. The fibres showed a necrotic response to statin administration that matched their oxidative/glycolytic metabolic nature: Least sensitive --> I < - > IIA < - > IID < - > IIB <-- most sensitive. Type I and IIB fibres represent metabolic extremes of a continuum of metabolic properties through the fibre types with type I fibres most oxidative in metabolism and type IIB fibres most glycolytic. In addition, in some (nonnecrotic) glycolytic fibres from muscles showing early multifocal single fibre necrosis the only subcellular alterations present in isolation of any other changes were mitochondrial. These changes were characterised by an increased incidence of vacuolation and the formation of myelinoid vesicular bodies that accumulated in the subsarcolemmal areas. These findings suggest an important early involvement of mitochondria in selective glycolytic muscle fibre necrosis following inhibition of the enzyme HMG-CoA reductase.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15902968     DOI: 10.1080/01926230590908213

Source DB:  PubMed          Journal:  Toxicol Pathol        ISSN: 0192-6233            Impact factor:   1.902


  35 in total

1.  Rhabdomyolysis caused by an interaction of simvastatin and fusidic acid.

Authors:  Roselle Herring; Gordon Caldwell; Stuart Wade
Journal:  BMJ Case Rep       Date:  2009-09-20

2.  Statin-induced calcific Achilles tendinopathy in rats: comparison of biomechanical and histopathological effects of simvastatin, atorvastatin and rosuvastatin.

Authors:  Ferda Kaleağasıoğlu; Ercan Olcay; Vakur Olgaç
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2015-08-15       Impact factor: 4.342

3.  Novel effects of simvastatin on uterine fibroid tumors: in vitro and patient-derived xenograft mouse model study.

Authors:  Mostafa A Borahay; Kathleen Vincent; Massoud Motamedi; Elena Sbrana; Gokhan S Kilic; Ayman Al-Hendy; Darren Boehning
Journal:  Am J Obstet Gynecol       Date:  2015-03-31       Impact factor: 8.661

4.  A Peculiar Formula of Essential Amino Acids Prevents Rosuvastatin Myopathy in Mice.

Authors:  Giuseppe D'Antona; Laura Tedesco; Chiara Ruocco; Giovanni Corsetti; Maurizio Ragni; Andrea Fossati; Elisa Saba; Francesca Fenaroli; Mery Montinaro; Michele O Carruba; Alessandra Valerio; Enzo Nisoli
Journal:  Antioxid Redox Signal       Date:  2016-07-14       Impact factor: 8.401

5.  Statin therapy and the expression of genes that regulate calcium homeostasis and membrane repair in skeletal muscle.

Authors:  Annette Draeger; Verónica Sanchez-Freire; Katia Monastyrskaya; Hans Hoppeler; Matthias Mueller; Fabio Breil; Markus G Mohaupt; Eduard B Babiychuk
Journal:  Am J Pathol       Date:  2010-05-20       Impact factor: 4.307

Review 6.  The effects of statin medications on aerobic exercise capacity and training adaptations.

Authors:  Zsolt Murlasits; Zsolt Radák
Journal:  Sports Med       Date:  2014-11       Impact factor: 11.136

7.  Development of a neurotoxicity assay that is tuned to detect mitochondrial toxicants.

Authors:  Johannes Delp; Melina Funke; Franziska Rudolf; Andrea Cediel; Susanne Hougaard Bennekou; Wanda van der Stel; Giada Carta; Paul Jennings; Cosimo Toma; Iain Gardner; Bob van de Water; Anna Forsby; Marcel Leist
Journal:  Arch Toxicol       Date:  2019-06-12       Impact factor: 5.153

8.  Tissue-Engineered Human Myobundle System as a Platform for Evaluation of Skeletal Muscle Injury Biomarkers.

Authors:  Alastair Khodabukus; Amulya Kaza; Jason Wang; Neel Prabhu; Richard Goldstein; Vishal S Vaidya; Nenad Bursac
Journal:  Toxicol Sci       Date:  2020-07-01       Impact factor: 4.849

9.  The muscle-specific ubiquitin ligase atrogin-1/MAFbx mediates statin-induced muscle toxicity.

Authors:  Jun-ichi Hanai; Peirang Cao; Preeti Tanksale; Shintaro Imamura; Eriko Koshimizu; Jinghui Zhao; Shuji Kishi; Michiaki Yamashita; Paul S Phillips; Vikas P Sukhatme; Stewart H Lecker
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

10.  Interaction between rosuvastatin and rocuronium in rat sciatic-gastrocnemius nerve-muscle preparation.

Authors:  Ashwin K Panchasara; Jayshree C Patel; Vishalkumar K Vadgama; Manish J Barvaliya; C B Tripathi
Journal:  J Anesth       Date:  2014-02-21       Impact factor: 2.078

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.